Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus
- PMID: 1396013
- DOI: 10.2337/diacare.15.9.1156
Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus
Abstract
In this review, we have highlighted pivotal cellular and molecular events in the initiation and progression of atherosclerosis. Key components of lesion initiation are an enhanced focal intimal influx and accumulation of lipoproteins, including LDL in hemodynamically determined lesion-prone areas, focal monocyte-macrophage recruitment, intimal generation of ROS, and oxidative modification of lipoproteins (including LDL [Ox-LDL]). Modified lipoproteins are taken up by the non-downregulating macrophage scavenger receptor, with foam cell formation and the development of the so-called fatty streak. One transitional event in lesion progression is foam cell necrosis, likely attributable to the cytotoxicity of both intimal free radicals and Ox-LDL, with development of an extracellular metabolically inert lipid core. Another is the migration to and proliferation within the intima of medial SMCs, leading to the synthesis of plaque collagens, elastin, and proteoglycans. Mural thrombosis plays a significant role in the late-stage progression of lesions. Regression of lesions is considered a function of the dynamic balance among components of initiation, progression, plaque stabilization, and removal of plaque constituents--the so-called regression quartet. Here, we critically examine how components of diabetes mellitus might impact not only lesion development, but also lesion regression. It is concluded that some components of diabetes mellitus augment key mechanisms in lesion initiation and progression and will likely retard the processes of plaque regression. Specifically, we focus on the various influences of diabetes mellitus on lipoprotein influx and accumulation, free radical generation and Ox-LDL, monocyte-macrophage recruitment, thrombosis and impaired fibrinolysis, and the reverse cholesterol transport system. The importance of nonenzymatic protein glycosylation in modifying a number of these processes is emphasized.
Similar articles
-
The pathogenesis of atherosclerosis: an overview.Clin Cardiol. 1991 Feb;14(2 Suppl 1):I1-16. doi: 10.1002/clc.4960141302. Clin Cardiol. 1991. PMID: 2044253 Review.
-
A modern view of atherogenesis.Am J Cardiol. 1993 Feb 25;71(6):9B-14B. doi: 10.1016/0002-9149(93)90139-4. Am J Cardiol. 1993. PMID: 8434561 Review.
-
Atherosclerosis. Potential targets for stabilization and regression.Circulation. 1992 Dec;86(6 Suppl):III117-23. Circulation. 1992. PMID: 1424045 Review.
-
The role of oxidized low density lipoprotein in atherogenesis.J Nutr. 1996 Apr;126(4 Suppl):1053S-7S. doi: 10.1093/jn/126.suppl_4.1053S. J Nutr. 1996. PMID: 8642431 Review.
-
The role of lipoproteins in atherogenesis.Adv Exp Med Biol. 1995;369:29-38. doi: 10.1007/978-1-4615-1957-7_4. Adv Exp Med Biol. 1995. PMID: 7598014 Review.
Cited by
-
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study.BMJ. 1996 Sep 14;313(7058):660-3. doi: 10.1136/bmj.313.7058.660. BMJ. 1996. PMID: 8811759 Free PMC article.
-
Cardiovascular disease and diabetes: modifying risk factors other than glucose control.Ochsner J. 2001 Jul;3(3):132-7. Ochsner J. 2001. PMID: 22754389 Free PMC article.
-
Formyl peptide receptor 1 and its antagonist T0080 in atherosclerosis.Cell Death Differ. 2025 Apr 9. doi: 10.1038/s41418-025-01506-7. Online ahead of print. Cell Death Differ. 2025. PMID: 40204950
-
Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients.Lipids Health Dis. 2011 Dec 6;10:228. doi: 10.1186/1476-511X-10-228. Lipids Health Dis. 2011. PMID: 22142413 Free PMC article.
-
The pathomorphological alterations of endocardial endothelium in experimental diabetes and diabetes associated with hyperlipidemia.Acta Diabetol. 1996 Mar;33(1):41-7. doi: 10.1007/BF00571939. Acta Diabetol. 1996. PMID: 8777284
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
